In last trading session, GeneDx Holdings Corp (NASDAQ:WGS) saw 0.41 million shares changing hands with its beta currently measuring 2.37. Company’s recent per share price level of $42.79 trading at $2.17 or 5.34% at ring of the bell on the day assigns it a market valuation of $1.15B. That closing price of WGS’s stock is at a discount of -1.24% from its 52-week high price of $43.32 and is indicating a premium of 97.29% from its 52-week low price of $1.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.44 million shares which gives us an average trading volume of 452.54K if we extend that period to 3-months.
For GeneDx Holdings Corp (WGS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.21 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Upright in the green during last session for gaining 5.34%, in the last five days WGS remained trading in the green while hitting it’s week-highest on Friday, 09/27/24 when the stock touched $42.79 price level, adding 0.4% to its value on the day. GeneDx Holdings Corp’s shares saw a change of 1456.00% in year-to-date performance and have moved 5.92% in past 5-day. GeneDx Holdings Corp (NASDAQ:WGS) showed a performance of 35.03% in past 30-days. Number of shares sold short was 2.22 million shares which calculate 6.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 38.5 to the stock, which implies a fall of -11.14% to its current value. Analysts have been projecting 21 as a low price target for the stock while placing it at a high target of 45. It follows that stock’s current price would jump 50.92% in reaching the projected high whereas dropping to the targeted low would mean a gain of 50.92% for stock’s current value.
GeneDx Holdings Corp (WGS) estimates and forecasts
Statistics highlight that GeneDx Holdings Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 368.67% of value to its shares in past 6 months, showing an annual growth rate of 85.55% while that of industry is 7.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 30.00% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 64.99M for the same. And 6 analysts are in estimates of company making revenue of 67.13M in the next quarter. Company posted 53.3M and 57.42M of sales in current and next quarters respectively a year earlier.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
Insiders are in possession of 25.40% of company’s total shares while institution are holding 62.15 percent of that, with stock having share float percentage of 83.31%. Investors also watch the number of corporate investors in a company very closely, which is 62.15% institutions for GeneDx Holdings Corp that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024 , the former fund manager was holding 410.78 shares of worth $17.58 million or 1.53% of the total outstanding shares. The later fund manager was in possession of 333.59 shares on Aug 31, 2024 , making its stake of worth around $14.27 million in the company or a holder of 1.24% of company’s stock.
